Abstract |
In a phase I/II study, the new fluorescence marker 5-aminofluorescein covalently bound to human serum albumin (AFL-HSA) was intravenously administered to 10 patients with brain tumor 1 to 4 days before surgery, and AFL-HSA kinetics were determined to assess the optimum timing of dye administration. AFL-HSA was determined in serum and brain tissue by size exclusion chromatography with fluorescence detection. AFL-HSA disposition was quite similar to albumin kinetics with small volumes of distribution (volume of central compartment [V(c)] = 2.4 L; volume of distribution [Vd(β)] = 6.8 L; volume at steady state [V(ss)] = 5.9 L), a low clearance (mean Cl = 16.85 mL/h), and a long elimination half-life (mean T(1/2;β) = 307 hours). Predicted peak concentrations in the peripheral compartment occurred at 80.9 hours, the time point of optimal fluorescence intensity observed in brain tumors during surgery.
|
Authors | Reinhard Ding, Eva Frei, Mahmoudreza Fardanesh, Hans-Hermann Schrenk, Paul Kremer, Walter E Haefeli |
Journal | Journal of clinical pharmacology
(J Clin Pharmacol)
Vol. 51
Issue 5
Pg. 672-8
(May 2011)
ISSN: 1552-4604 [Electronic] England |
PMID | 20978277
(Publication Type: Clinical Trial, Phase I, Clinical Trial, Phase II, Journal Article)
|
Chemical References |
- Fluoresceins
- Fluorescent Dyes
- Serum Albumin
- 5-aminofluorescein
|
Topics |
- Aged
- Brain Neoplasms
(metabolism, surgery)
- Chromatography, Gel
- Chromatography, High Pressure Liquid
- Female
- Fluoresceins
(administration & dosage, pharmacokinetics)
- Fluorescent Dyes
(administration & dosage, pharmacokinetics)
- Germany
- Half-Life
- Humans
- Infusions, Intravenous
- Male
- Metabolic Clearance Rate
- Middle Aged
- Models, Biological
- Molecular Probe Techniques
- Monitoring, Intraoperative
(methods)
- Neurosurgical Procedures
- Serum Albumin
(administration & dosage, pharmacokinetics)
- Spectrometry, Fluorescence
- Tissue Distribution
|